{"id":14513,"date":"2023-02-24T15:29:22","date_gmt":"2023-02-24T08:29:22","guid":{"rendered":"https:\/\/hpsp-prod.th1.proen.cloud\/%e0%b8%a1%e0%b8%b0%e0%b9%80%e0%b8%a3%e0%b9%87%e0%b8%87%e0%b9%80%e0%b8%95%e0%b9%89%e0%b8%b2%e0%b8%99%e0%b8%a1\/"},"modified":"2023-03-06T15:39:37","modified_gmt":"2023-03-06T08:39:37","slug":"breast-cancer","status":"publish","type":"post","link":"https:\/\/hpsp.or.th\/en\/breast-cancer\/","title":{"rendered":"Breast Cancer"},"content":{"rendered":"<section class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][vc_column_text]<\/p>\n<h1><b>Breast Cancer<\/b><\/h1>\n<p><b>Title: Acute skin toxicity and cosmesis outcome in ultrahypofractionated radiotherapy for non-metastatic breast cancer treated with proton radiotherapy compared with photon radiotherapy: a randomized control trial phase ll.\u00a0\u00a0<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Trial status: recruiting<\/span><\/p>\n<p><span style=\"font-weight: 400;\">First posted: 30 January 2023<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Last updated: 30 January 2023<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u00a0<\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=&#8221;stretch_row&#8221; content_placement=&#8221;middle&#8221; css=&#8221;.vc_custom_1678088361697{background-color: #eff3fa !important;}&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_column_text]<strong>Purpose<br \/>\n<\/strong><span style=\"font-weight: 400;\">\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0Nowadays, the main treatment for breast cancer includes surgery, chemotherapy, targeted treatment, and radiotherapy. Radiotherapy after surgery has reduced the recurrence rate and mortality rate of the disease. Over the past 10 years, the standard treatment for early breast cancer in many countries, including King Chulalongkorn Memorial Hospital, has been reducing the number of doses of radiation from 50-60 Gray in 25-30 days to 40.5 Gray in 15 days, known as &#8220;hypofractionation.&#8221; Studies conducted in various countries have shown that this hypofractionation has no impact on disease control, making it more convenient for patients by reducing the number of visits to the hospital and increasing access to radiation treatment for new patients. In the past 5 years, the number of radiation doses for early breast cancer patients has been reduced to 26 Gray in 5 days. To determine the optimal radiation dose that would most benefit the patient, a recent study from the UK showed that this reduced dose of 26 Gray over 5 days was not inferior to the hypofractionation method of 40.5 Gray over 15 days and had no significant difference in terms of side effects, with minimal acute dermatitis. King Chulalongkorn Memorial Hospital has also introduced a radiation service using proton therapy, which is the first machine of its kind in Thailand. This proton therapy is superior to the current photon irradiation in terms of reducing side effects on surrounding organs and tissues, particularly for the treatment of breast cancer, where the heart and lungs are nearby.<\/span>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;14964&#8243; img_size=&#8221;full&#8221; style=&#8221;vc_box_shadow_border&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<span style=\"font-weight: 400;\">This research is a comparative study between photon and proton irradiation. The objectives of this study are:<\/span><\/p>\n<ol>\n<li><span style=\"font-weight: 400;\">To assess acute skin toxicities in PRT when using ultrahypofractioned radiation in non-metastatic breast cancer compare to photon beam radiotherapy.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">To evaluate<\/span> <span style=\"font-weight: 400;\">the LRR of non-metastatic breast cancer after treated by the PRT with ultrahypofractioned radiation compare to photon beam radiotherapy.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">To evaluate the cosmetic outcome of the PRT when using ultrahypofractioned radiation in non-metastatic breast cancer compare to photon beam radiotherapy.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">To evaluate the late toxicities and late cosmetic outcome of the PRT when using ultrahypofractioned radiation compare to photon beam radiotherapy.<\/span><\/li>\n<\/ol>\n<p><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Sample size 140 patients<\/span><\/p>\n<p><strong>Eligibility:<\/strong><\/p>\n<p><strong>Inclusion criteria:<\/strong><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Female patients who diagnosed with pathologically proven breast cancer and have undergone either mastectomy or lumpectomy with axillary lymph node dissection or sentinel lymph node biopsy.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Stage 1-3 (According to AJCC 8<\/span><span style=\"font-weight: 400;\">th<\/span><span style=\"font-weight: 400;\"> edition)<\/span><span style=\"font-weight: 400;\">[21]<\/span><span style=\"font-weight: 400;\"> (Appendix 6)<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Aged <\/span><span style=\"font-weight: 400;\">\u2265<\/span><span style=\"font-weight: 400;\"> 21years.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">ECOG performance status 0-2 (asymptomatic or symptomatic but capable for self-care) within 90 days prior to randomization.<\/span><\/li>\n<\/ul>\n<p><strong>Exclusion criteria:<\/strong><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Prior radiotherapy to the ipsilateral chest wall or ipsilateral breast\/thorax.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Any radiation therapy for the currently diagnosed breast cancer prior to randomization.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Any active skin problem on chest wall and axillary area or connective tissue disease.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Other non-malignant systemic disease that would prevent the patient from receiving study treatment or required follow-up including pregnancy or lactating.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Surgical margin positive.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Bilateral breast cancer.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><strong>Phase II<\/strong><\/p>\n<p><span style=\"font-weight: 400;\"><strong>Disease Status :<\/strong> <\/span><span style=\"font-weight: 400;\">Stage I-III<\/span><\/p>\n<p><strong>Investigator<\/strong><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Chawalit Lertbutsayanukul<\/span><\/li>\n<li>Thanaporn Sarsitthithum<\/li>\n<li>Chonnipa Nantavithya<\/li>\n<li>Kitwadee Saksornchai<\/li>\n<\/ul>\n<p><strong>Diseases : <\/strong><span style=\"font-weight: 400;\">Breast cancer<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><strong>Locations :<\/strong> <\/span><span style=\"font-weight: 400;\">King Chulalongkorn Memorial hospital<\/span>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/section>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text] Breast Cancer Title: Acute skin toxicity and cosmesis outcome in ultrahypofractionated radiotherapy for non-metastatic breast cancer treated with proton radiotherapy compared with photon radiotherapy: a randomized control trial phase ll.\u00a0\u00a0 Trial status: recruiting First posted: 30 January 2023 Last updated: 30 January 2023 \u00a0[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=&#8221;stretch_row&#8221; content_placement=&#8221;middle&#8221; css=&#8221;.vc_custom_1678088361697{background-color: #eff3fa !important;}&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_column_text]Purpose \u00a0 \u00a0 \u00a0 \u00a0<\/p>\n","protected":false},"author":1,"featured_media":14964,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[174],"tags":[],"type_post":[],"class_list":["post-14513","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.2.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Breast Cancer - HPSP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hpsp.or.th\/en\/breast-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Breast Cancer - HPSP\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_column_text] Breast Cancer Title: Acute skin toxicity and cosmesis outcome in ultrahypofractionated radiotherapy for non-metastatic breast cancer treated with proton radiotherapy compared with photon radiotherapy: a randomized control trial phase ll.\u00a0\u00a0 Trial status: recruiting First posted: 30 January 2023 Last updated: 30 January 2023 \u00a0[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=&#8221;stretch_row&#8221; content_placement=&#8221;middle&#8221; css=&#8221;.vc_custom_1678088361697{background-color: #eff3fa !important;}&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_column_text]Purpose \u00a0 \u00a0 \u00a0 \u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hpsp.or.th\/en\/breast-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"HPSP\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-24T08:29:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-06T08:39:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hpsp.or.th\/wp-content\/uploads\/2023\/02\/\u0e21\u0e30\u0e40\u0e23\u0e47\u0e07\u0e40\u0e15\u0e49\u0e32\u0e19\u0e21-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"hpsp.or.th@gmail.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hpsp.or.th@gmail.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/hpsp.or.th\/en\/breast-cancer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/hpsp.or.th\/en\/breast-cancer\/\"},\"author\":{\"name\":\"hpsp.or.th@gmail.com\",\"@id\":\"https:\/\/hpsp.or.th\/#\/schema\/person\/94efc677e81b8adf6e71004bb9029e7b\"},\"headline\":\"Breast Cancer\",\"datePublished\":\"2023-02-24T08:29:22+00:00\",\"dateModified\":\"2023-03-06T08:39:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/hpsp.or.th\/en\/breast-cancer\/\"},\"wordCount\":602,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/hpsp.or.th\/#organization\"},\"articleSection\":[\"research\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/hpsp.or.th\/en\/breast-cancer\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/hpsp.or.th\/en\/breast-cancer\/\",\"url\":\"https:\/\/hpsp.or.th\/en\/breast-cancer\/\",\"name\":\"Breast Cancer - HPSP\",\"isPartOf\":{\"@id\":\"https:\/\/hpsp.or.th\/#website\"},\"datePublished\":\"2023-02-24T08:29:22+00:00\",\"dateModified\":\"2023-03-06T08:39:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/hpsp.or.th\/en\/breast-cancer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/hpsp.or.th\/en\/breast-cancer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/hpsp.or.th\/en\/breast-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/hpsp.or.th\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Breast Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/hpsp.or.th\/#website\",\"url\":\"https:\/\/hpsp.or.th\/\",\"name\":\"\u0e28\u0e39\u0e19\u0e22\u0e4c\u0e42\u0e1b\u0e23\u0e15\u0e2d\u0e19\u0e2a\u0e21\u0e40\u0e14\u0e47\u0e08\u0e1e\u0e23\u0e30\u0e40\u0e17\u0e1e\u0e23\u0e31\u0e15\u0e19\u0e23\u0e32\u0e0a\u0e2a\u0e38\u0e14\u0e32\u0e2f \u0e42\u0e23\u0e07\u0e1e\u0e22\u0e32\u0e1a\u0e32\u0e25\u0e08\u0e38\u0e2c\u0e32\u0e25\u0e07\u0e01\u0e23\u0e13\u0e4c\",\"description\":\"\u0e28\u0e39\u0e19\u0e22\u0e4c\u0e42\u0e1b\u0e23\u0e15\u0e2d\u0e19\u0e2a\u0e21\u0e40\u0e14\u0e47\u0e08\u0e1e\u0e23\u0e30\u0e40\u0e17\u0e1e\u0e23\u0e31\u0e15\u0e19\u0e23\u0e32\u0e0a\u0e2a\u0e38\u0e14\u0e32\u0e2f \u0e42\u0e23\u0e07\u0e1e\u0e22\u0e32\u0e1a\u0e32\u0e25\u0e08\u0e38\u0e2c\u0e32\u0e25\u0e07\u0e01\u0e23\u0e13\u0e4c \u0e2a\u0e20\u0e32\u0e01\u0e32\u0e0a\u0e32\u0e14\u0e44\u0e17\u0e22\",\"publisher\":{\"@id\":\"https:\/\/hpsp.or.th\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/hpsp.or.th\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/hpsp.or.th\/#organization\",\"name\":\"\u0e28\u0e39\u0e19\u0e22\u0e4c\u0e42\u0e1b\u0e23\u0e15\u0e2d\u0e19\u0e2a\u0e21\u0e40\u0e14\u0e47\u0e08\u0e1e\u0e23\u0e30\u0e40\u0e17\u0e1e\u0e23\u0e31\u0e15\u0e19\u0e23\u0e32\u0e0a\u0e2a\u0e38\u0e14\u0e32\u0e2f \u0e42\u0e23\u0e07\u0e1e\u0e22\u0e32\u0e1a\u0e32\u0e25\u0e08\u0e38\u0e2c\u0e32\u0e25\u0e07\u0e01\u0e23\u0e13\u0e4c\",\"url\":\"https:\/\/hpsp.or.th\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hpsp.or.th\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/hpsp-prod.th1.proen.cloud\/wp-content\/uploads\/2023\/03\/HPSP-Social-Share.jpg\",\"contentUrl\":\"https:\/\/hpsp-prod.th1.proen.cloud\/wp-content\/uploads\/2023\/03\/HPSP-Social-Share.jpg\",\"width\":1200,\"height\":630,\"caption\":\"\u0e28\u0e39\u0e19\u0e22\u0e4c\u0e42\u0e1b\u0e23\u0e15\u0e2d\u0e19\u0e2a\u0e21\u0e40\u0e14\u0e47\u0e08\u0e1e\u0e23\u0e30\u0e40\u0e17\u0e1e\u0e23\u0e31\u0e15\u0e19\u0e23\u0e32\u0e0a\u0e2a\u0e38\u0e14\u0e32\u0e2f \u0e42\u0e23\u0e07\u0e1e\u0e22\u0e32\u0e1a\u0e32\u0e25\u0e08\u0e38\u0e2c\u0e32\u0e25\u0e07\u0e01\u0e23\u0e13\u0e4c\"},\"image\":{\"@id\":\"https:\/\/hpsp.or.th\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/hpsp.or.th\/#\/schema\/person\/94efc677e81b8adf6e71004bb9029e7b\",\"name\":\"hpsp.or.th@gmail.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hpsp.or.th\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/38dca655bf214dcfdab92db73d7ba6f43a3a77af390e23fbf7c59d604aa6be67?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/38dca655bf214dcfdab92db73d7ba6f43a3a77af390e23fbf7c59d604aa6be67?s=96&d=mm&r=g\",\"caption\":\"hpsp.or.th@gmail.com\"},\"sameAs\":[\"https:\/\/hpsp-or-th.th1.proen.cloud\"],\"url\":\"https:\/\/hpsp.or.th\/en\/author\/hpsp-or-thgmail-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Breast Cancer - HPSP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hpsp.or.th\/en\/breast-cancer\/","og_locale":"en_US","og_type":"article","og_title":"Breast Cancer - HPSP","og_description":"[vc_row][vc_column][vc_column_text] Breast Cancer Title: Acute skin toxicity and cosmesis outcome in ultrahypofractionated radiotherapy for non-metastatic breast cancer treated with proton radiotherapy compared with photon radiotherapy: a randomized control trial phase ll.\u00a0\u00a0 Trial status: recruiting First posted: 30 January 2023 Last updated: 30 January 2023 \u00a0[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=&#8221;stretch_row&#8221; content_placement=&#8221;middle&#8221; css=&#8221;.vc_custom_1678088361697{background-color: #eff3fa !important;}&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_column_text]Purpose \u00a0 \u00a0 \u00a0 \u00a0","og_url":"https:\/\/hpsp.or.th\/en\/breast-cancer\/","og_site_name":"HPSP","article_published_time":"2023-02-24T08:29:22+00:00","article_modified_time":"2023-03-06T08:39:37+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/hpsp.or.th\/wp-content\/uploads\/2023\/02\/\u0e21\u0e30\u0e40\u0e23\u0e47\u0e07\u0e40\u0e15\u0e49\u0e32\u0e19\u0e21-2.jpg","type":"image\/jpeg"}],"author":"hpsp.or.th@gmail.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"hpsp.or.th@gmail.com","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hpsp.or.th\/en\/breast-cancer\/#article","isPartOf":{"@id":"https:\/\/hpsp.or.th\/en\/breast-cancer\/"},"author":{"name":"hpsp.or.th@gmail.com","@id":"https:\/\/hpsp.or.th\/#\/schema\/person\/94efc677e81b8adf6e71004bb9029e7b"},"headline":"Breast Cancer","datePublished":"2023-02-24T08:29:22+00:00","dateModified":"2023-03-06T08:39:37+00:00","mainEntityOfPage":{"@id":"https:\/\/hpsp.or.th\/en\/breast-cancer\/"},"wordCount":602,"commentCount":0,"publisher":{"@id":"https:\/\/hpsp.or.th\/#organization"},"articleSection":["research"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/hpsp.or.th\/en\/breast-cancer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/hpsp.or.th\/en\/breast-cancer\/","url":"https:\/\/hpsp.or.th\/en\/breast-cancer\/","name":"Breast Cancer - HPSP","isPartOf":{"@id":"https:\/\/hpsp.or.th\/#website"},"datePublished":"2023-02-24T08:29:22+00:00","dateModified":"2023-03-06T08:39:37+00:00","breadcrumb":{"@id":"https:\/\/hpsp.or.th\/en\/breast-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hpsp.or.th\/en\/breast-cancer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/hpsp.or.th\/en\/breast-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hpsp.or.th\/en\/"},{"@type":"ListItem","position":2,"name":"Breast Cancer"}]},{"@type":"WebSite","@id":"https:\/\/hpsp.or.th\/#website","url":"https:\/\/hpsp.or.th\/","name":"\u0e28\u0e39\u0e19\u0e22\u0e4c\u0e42\u0e1b\u0e23\u0e15\u0e2d\u0e19\u0e2a\u0e21\u0e40\u0e14\u0e47\u0e08\u0e1e\u0e23\u0e30\u0e40\u0e17\u0e1e\u0e23\u0e31\u0e15\u0e19\u0e23\u0e32\u0e0a\u0e2a\u0e38\u0e14\u0e32\u0e2f \u0e42\u0e23\u0e07\u0e1e\u0e22\u0e32\u0e1a\u0e32\u0e25\u0e08\u0e38\u0e2c\u0e32\u0e25\u0e07\u0e01\u0e23\u0e13\u0e4c","description":"\u0e28\u0e39\u0e19\u0e22\u0e4c\u0e42\u0e1b\u0e23\u0e15\u0e2d\u0e19\u0e2a\u0e21\u0e40\u0e14\u0e47\u0e08\u0e1e\u0e23\u0e30\u0e40\u0e17\u0e1e\u0e23\u0e31\u0e15\u0e19\u0e23\u0e32\u0e0a\u0e2a\u0e38\u0e14\u0e32\u0e2f \u0e42\u0e23\u0e07\u0e1e\u0e22\u0e32\u0e1a\u0e32\u0e25\u0e08\u0e38\u0e2c\u0e32\u0e25\u0e07\u0e01\u0e23\u0e13\u0e4c \u0e2a\u0e20\u0e32\u0e01\u0e32\u0e0a\u0e32\u0e14\u0e44\u0e17\u0e22","publisher":{"@id":"https:\/\/hpsp.or.th\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hpsp.or.th\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/hpsp.or.th\/#organization","name":"\u0e28\u0e39\u0e19\u0e22\u0e4c\u0e42\u0e1b\u0e23\u0e15\u0e2d\u0e19\u0e2a\u0e21\u0e40\u0e14\u0e47\u0e08\u0e1e\u0e23\u0e30\u0e40\u0e17\u0e1e\u0e23\u0e31\u0e15\u0e19\u0e23\u0e32\u0e0a\u0e2a\u0e38\u0e14\u0e32\u0e2f \u0e42\u0e23\u0e07\u0e1e\u0e22\u0e32\u0e1a\u0e32\u0e25\u0e08\u0e38\u0e2c\u0e32\u0e25\u0e07\u0e01\u0e23\u0e13\u0e4c","url":"https:\/\/hpsp.or.th\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hpsp.or.th\/#\/schema\/logo\/image\/","url":"https:\/\/hpsp-prod.th1.proen.cloud\/wp-content\/uploads\/2023\/03\/HPSP-Social-Share.jpg","contentUrl":"https:\/\/hpsp-prod.th1.proen.cloud\/wp-content\/uploads\/2023\/03\/HPSP-Social-Share.jpg","width":1200,"height":630,"caption":"\u0e28\u0e39\u0e19\u0e22\u0e4c\u0e42\u0e1b\u0e23\u0e15\u0e2d\u0e19\u0e2a\u0e21\u0e40\u0e14\u0e47\u0e08\u0e1e\u0e23\u0e30\u0e40\u0e17\u0e1e\u0e23\u0e31\u0e15\u0e19\u0e23\u0e32\u0e0a\u0e2a\u0e38\u0e14\u0e32\u0e2f \u0e42\u0e23\u0e07\u0e1e\u0e22\u0e32\u0e1a\u0e32\u0e25\u0e08\u0e38\u0e2c\u0e32\u0e25\u0e07\u0e01\u0e23\u0e13\u0e4c"},"image":{"@id":"https:\/\/hpsp.or.th\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/hpsp.or.th\/#\/schema\/person\/94efc677e81b8adf6e71004bb9029e7b","name":"hpsp.or.th@gmail.com","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hpsp.or.th\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/38dca655bf214dcfdab92db73d7ba6f43a3a77af390e23fbf7c59d604aa6be67?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/38dca655bf214dcfdab92db73d7ba6f43a3a77af390e23fbf7c59d604aa6be67?s=96&d=mm&r=g","caption":"hpsp.or.th@gmail.com"},"sameAs":["https:\/\/hpsp-or-th.th1.proen.cloud"],"url":"https:\/\/hpsp.or.th\/en\/author\/hpsp-or-thgmail-com\/"}]}},"_links":{"self":[{"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/posts\/14513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/comments?post=14513"}],"version-history":[{"count":6,"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/posts\/14513\/revisions"}],"predecessor-version":[{"id":15405,"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/posts\/14513\/revisions\/15405"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/media\/14964"}],"wp:attachment":[{"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/media?parent=14513"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/categories?post=14513"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/tags?post=14513"},{"taxonomy":"type_post","embeddable":true,"href":"https:\/\/hpsp.or.th\/en\/wp-json\/wp\/v2\/type_post?post=14513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}